Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Thomas W. Butler"'
Autor:
Hamza Khan, Deepa Cherla, Krista Mehari, Manish Tripathi, Thomas W. Butler, Errol D. Crook, Martin J. Heslin, Fabian M. Johnston, Annabelle L. Fonseca
Publikováno v:
Annals of Surgical Oncology. 30:179-188
Autor:
Hamza Khan, Deepa Cherla, Krista Mehari, Manish Tripathi, Thomas W. Butler, Errol D. Crook, Martin J. Heslin, Fabian M. Johnston, Annabelle L. Fonseca
Publikováno v:
Annals of surgical oncology. 30(1)
Autor:
Margaret I. Fitch, Penelope Schofield, Thomas W. Butler, Sahil Suleman, Georgia Halkett, Laura Inhestern, Jamie Hegel, Lauren J. Breen, Clare S. Rees
Publikováno v:
Mindfulness
Objectives Oncology health professionals experience high levels of burnout and compassion fatigue, affecting their health and the care they provide. This study aimed to establish whether present-centered awareness and attention (a component of mindfu
Autor:
Thomas W. Butler, Gabrielle B. Rocque, Edward E. Partridge, Karina I. Halilova, Patricia Drentea, J. Nicholas Dionne-Odom, Elizabeth Kvale, Chao-Hui Huang, Kerri S. Bevis, Soumya J. Niranjan, Maria Pisu
Publikováno v:
Journal of Palliative Care. 33:70-78
Context: Respecting Choices is an evidence-based model of facilitating advance care planning (ACP) conversations between health-care professionals and patients. However, the effectiveness of whether lay patient navigators can successfully initiate Re
Improving shared decision-making in chronic lymphocytic leukemia through multidisciplinary education
Autor:
Emily Sherene Van Laar, Uma Borate, Maria Pisu, Karina I. Halilova, Randall S. Davis, Bradford E. Jackson, Monika M. Safford, Gabrielle B. Rocque, Sara J. Knight, Thomas W. Butler, Courtney P. Williams, Amitkumar Mehta
Publikováno v:
Translational Behavioral Medicine. 8:175-182
New treatments for chronic lymphocytic leukemia (CLL) with excellent response rates and varying toxicity profiles have emerged in recent years, creating an opportunity for a patient's personal preferences to contribute to treatment decisions. We cond
Autor:
Abhijit Ray, Matthew Van Brocklin, Adam L. Cohen, Hung T. Khong, Donna Lynn Dyess, Thomas W. Butler, Randy C. Bowen, Theresa Liu Dumlao, David M. Burnett
Publikováno v:
Oncotarget
// Adam L. Cohen 1, * , Abhijit Ray 2, * , Matthew Van Brocklin 3 , David M. Burnett 3 , Randy C. Bowen 4 , Donna L. Dyess 5 , Thomas W. Butler 5 , Theresa Dumlao 6 and Hung T. Khong 1 1 Department of Medicine, Division of Oncology, University of Uta
Autor:
Gabrielle B. Rocque, J. Nicholas Dionne-Odom, Chao-Hui Sylvia Huang, Soumya J. Niranjan, Courtney P. Williams, Bradford E. Jackson, Karina I. Halilova, Kelly M. Kenzik, Kerri S. Bevis, Audrey S. Wallace, Nedra Lisovicz, Richard A. Taylor, Maria Pisu, Edward E. Partridge, Thomas W. Butler, Linda A. Briggs, Elizabeth A. Kvale, Lee Jackson, Zoe Scott, Guilherme Cantuaria, Debbie Bickes, Tina Berry, George Reiss, Hang Mai, Ming Chang, Louiz Gomez, Rhonda Meeker, James Clarkson, Maggie Clarkson, Steven Stokes, Tina Newman, Mary Sheffield, Ellen Spremulli, Wendy Watson, Tom Payne, Hanna Bright, Stacey Holman, Thomas Butler, Cathy Tinnea, Fred Schnell, Cyndi Pyle, Richard Taylor, Aras Acemgil, Xuelin Li, Wendy Demark-Wahnefried, Karen Meneses, Yufeng Li, Michelle Y. Martin, Carol Chambless, Valeria Pacheco-Rubi, Terri L. Salter, Warren Smedley, Mona Fouad
CONTEXT: Advance care planning (ACP) improves alignment between patient preferences for life-sustaining treatment and care received at end of life (EOL). OBJECTIVES: To evaluate implementation of lay navigator-led ACP. METHODS: A convergent, parallel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbbdc3dc14bc648b89f45a06e0b8809f
https://europepmc.org/articles/PMC6559345/
https://europepmc.org/articles/PMC6559345/
Autor:
Austin Cadden, Thomas W. Butler, Daniel Cameron, Cathy Tinnea, Susan T. Owenby, Sachin Gopalkrishn Pai, Jennifer Young Pierce, Debra Wujcik, Moh’d Khushman
Publikováno v:
Journal of Clinical Oncology. 37:88-88
88 Background: Treatment of lung cancer has seen a paradigm shift in recent years. While the availability of newer treatment options such as targeted therapy and immunotherapy have provided new hope for better outcomes, this has added to the cost of
Autor:
Donna Lynn Dyess, Abhijit Ray, Leigh Neumayer, Thomas W. Butler, Theresa L. Werner, Adam L. Cohen, Theresa Liu Dumlao, Anna C. Beck, Saundra S. Buys, Hung T. Khong, Kristin Hueftle, John G. Lamb, Matthew W. VanBrocklin
Publikováno v:
Clinical breast cancer. 17(7)
Background The aims of this study were to assess the safety and tolerability of nanoparticle albumin bound paclitaxel (nab-paclitaxel), doxorubicin, and cyclophosphamide as combination therapy for breast cancer patients in the neoadjuvant setting and
Publikováno v:
Case Reports in Hematology, Vol 2016 (2016)
Case Reports in Hematology
Case Reports in Hematology
Waldenstrom’s macroglobulinaemia is the most commonly reported subtype of lymphoplasmacytic lymphoma (LPL); it is characterised by IgM secretion. Neurological complications are common usually as a result of hyperviscosity. In rare cases, cells can